Abstract
10/2005
vol. 8
Current look at effects of long-term proton pump inhibitors therapy
Przew Lek 2005; 10; 52-57
Online publish date: 2005/12/22
Introduction of proton pump inhibitors (PPI) provided an important progress in treatment of the acid-related diseases. PPI are largely administered andand frequently used in long-term therapy. Hypergastrinaemia induced by PPI may lead in human to enterochromaffin-like cells hyperplasia. No neoplastic changes have been reported after more than a decade of use. Fat and mineral bioavailability remain unaltered by PPI therapy. However absorption and profound acid suppression for many years may lead to vitamin B12 deficiency.
Keywords
proton pump inhibitors, long-term therapy
Integrated with